225 related articles for article (PubMed ID: 31129031)
1. 15-Keto prostaglandin E
Lee EJ; Kim SJ; Hahn YI; Yoon HJ; Han B; Kim K; Lee S; Kim KP; Suh YG; Na HK; Surh YJ
Redox Biol; 2019 May; 23():101175. PubMed ID: 31129031
[TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-Δ
Kim SJ; Cho NC; Han B; Kim K; Hahn YI; Kim KP; Suh YG; Choi BY; Na HK; Surh YJ
FEBS Lett; 2021 Mar; 595(5):604-622. PubMed ID: 33452674
[TBL] [Abstract][Full Text] [Related]
3. 15-Keto prostaglandin E
Lee JE; Zhong X; Lee JY; Surh YJ; Na HK
Arch Biochem Biophys; 2020 Jan; 679():108162. PubMed ID: 31669540
[TBL] [Abstract][Full Text] [Related]
4. 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.
Lu D; Han C; Wu T
J Biol Chem; 2013 Jul; 288(27):19484-502. PubMed ID: 23687300
[TBL] [Abstract][Full Text] [Related]
5. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
[TBL] [Abstract][Full Text] [Related]
6. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
7. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
8. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
9. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
Zhao Q; Bi Y; Zhong J; Li X; Guo J; Liu YX; Pan LR; Tan Y; Deng ZS; Yu XJ
Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
[TBL] [Abstract][Full Text] [Related]
10. Curcumin interacts directly with the Cysteine 259 residue of STAT3 and induces apoptosis in H-Ras transformed human mammary epithelial cells.
Hahn YI; Kim SJ; Choi BY; Cho KC; Bandu R; Kim KP; Kim DH; Kim W; Park JS; Han BW; Lee J; Na HK; Cha YN; Surh YJ
Sci Rep; 2018 Apr; 8(1):6409. PubMed ID: 29686295
[TBL] [Abstract][Full Text] [Related]
11. 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.
Lu D; Han C; Wu T
Oncogene; 2014 Feb; 33(9):1101-12. PubMed ID: 23542179
[TBL] [Abstract][Full Text] [Related]
12. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T
PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012
[TBL] [Abstract][Full Text] [Related]
13. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
14. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
Wang J; Xu J; Xing G
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
[TBL] [Abstract][Full Text] [Related]
15. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
Kim HR; Lee HN; Lim K; Surh YJ; Na HK
Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy.
Frias MA; Rebsamen MC; Gerber-Wicht C; Lang U
Cardiovasc Res; 2007 Jan; 73(1):57-65. PubMed ID: 17067562
[TBL] [Abstract][Full Text] [Related]
17. mPGES-1-derived prostaglandin E2 stimulates Stat3 to promote podocyte apoptosis.
Yu J; Wu Y; Wang L; Zhang W; Xu M; Song J; Fu Y; Cui Y; Gong W; Li S; Xia W; Huang S; Zhang A; Jia Z
Apoptosis; 2017 Nov; 22(11):1431-1440. PubMed ID: 28879567
[TBL] [Abstract][Full Text] [Related]
18. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.
Leslie K; Gao SP; Berishaj M; Podsypanina K; Ho H; Ivashkiv L; Bromberg J
Breast Cancer Res; 2010; 12(5):R80. PubMed ID: 20929542
[TBL] [Abstract][Full Text] [Related]
19. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
[TBL] [Abstract][Full Text] [Related]
20. A natural compound derivative P-13 inhibits STAT3 signaling by covalently inhibiting Janus kinase 2.
Huang H; Niu J; Wang F; Hu L; Yu Q
Invest New Drugs; 2019 Jun; 37(3):452-460. PubMed ID: 30073465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
